Loading
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (4 ops.)
Latest filing published 15 Jun 2026 for Ategrity Specialty Insurance Co Holdings.
Filing timeline
BuySaleRobert C. Merton
Insider track record
Disclosed buys
8
Disclosed sells
4
Signal history
Closed purchases
Market purchases
8
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -10.9%Entry US$23.58 · Close at T+365 US$21.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert C. Merton: trading record in brief
Filings by Robert C. Merton span 2 companies, the busiest being Fresh Tracks Therapeutics, Inc. and Ategrity Specialty Insurance Co Holdings. The record holds 17 filings, for trades running from 21 May 2009 to 11 June 2026.
The open-market side counts 8 purchases for €854k alongside 4 sales for €18k. The net balance comes to €836k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants and 2 option exercises.
A typical purchase (the median) is worth €8,140. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The record was last updated on 15 June 2026 with an option exercise in Ategrity Specialty Insurance Co Holdings. The last insider purchase was made public on 16 June 2025, 495 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert C. Merton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
980 sharesCommon StockSEC:0001104659-26-074027:0
47,058 shares@ US$17.00100.0% of flowCommon StockSEC:0001104659-25-059970:0
Canonical exit: 10 Sept 2025 (T+90)
85,700 shares@ US$1.7571.0% of flowCommon Stock $.01 par valueSEC:0001209191-17-060540:0
Canonical exit: 8 Feb 2018 (T+90)
2,000 shares@ US$2.262.4% of flowCommon Stock $.01 par valueSEC:0001209191-16-156566:1
2,000 shares@ US$2.222.4% of flowCommon Stock $.01 par valueSEC:0001209191-16-156566:0
2,327 shares@ US$2.212.7% of flowCommon Stock $.01 par valueSEC:0001209191-16-156158:0
2,000 shares@ US$2.222.4% of flowCommon Stock $.01 par valueSEC:0001209191-16-156158:1
4,900 shares@ US$4.2910.3% of flowCommon Stock $.01 par valueSEC:0001209191-16-127752:0
Canonical exit: 11 Sept 2016 (T+90)
4,100 shares@ US$4.418.9% of flowCommon Stock $.01 par valueSEC:0001209191-16-127752:1
Canonical exit: 12 Sept 2016 (T+90)
5,953 shares@ US$0.01Common Stock $.01 par valueSEC:0001181431-13-031065:0
Canonical exit: 21 Aug 2013 (T+90)
12,500 shares@ US$3.59Common Stock $.01 par valueSEC:0001181431-13-027266:0
18,750 shares@ US$0.01Common Stock $.01 par valueSEC:0001181431-10-029723:0
Canonical exit: 23 Aug 2010 (T+90)
12 of 12 declarations
